Gaurav Shah, CEO at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 12,279 shares at $3.31 ($41K) on 2026-02-13, disclosed to the SEC on 2026-02-18.
Seasonal sale ($41k) by CEO — this insider has traded RCKT in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RCKT | SELL | 2026-05-26 | $172K | — | Filing → |
| RCKT | SELL | 2026-05-21 | $7K | — | Filing → |
| RCKT | SELL | 2026-05-14 | $10K | — | Filing → |